Showing results (1-10 of 196) with videos related to
Sort By:
Pageof 20
Cancer Research|July 2, 2009
Polyps wrap mast cells and Treg within tumorigenic tentaclesMario P Colombo, Silvia PiconeseNature Reviews. Cancer|October 25, 2007
Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapyMario P Colombo, Silvia PiconeseThe Journal of Experimental Medicine|March 26, 2008
OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejectionSilvia Piconese, Barbara Valzasina, Mario P ColomboFrontiers in Immunology|August 30, 2013
Convergences and divergences of thymus- and peripherally derived regulatory T cells in cancerAlessia Burocchi, Mario P Colombo, Silvia PiconeseCancer Research|April 19, 2006
Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independentBarbara Valzasina, Silvia Piconese, Cristiana Guiducci, et al.European Journal of Immunology|January 10, 2012
Intratumor OX40 stimulation inhibits IRF1 expression and IL-10 production by Treg cells while enhancing CD40L expression by effector memory T cellsAlessia Burocchi, Paola Pittoni, Andrea Gorzanelli, et al.European Journal of Immunology|September 1, 2010
A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2Silvia Piconese, Paola Pittoni, Alessia Burocchi, et al.Cancer Research|September 8, 2011
Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancersPaola Pittoni, Claudio Tripodo, Silvia Piconese, et al.Cancer Research|October 7, 2010
Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesisSabina Sangaletti, Claudio Tripodo, Chiara Ratti, et al.The Journal of Allergy and Clinical Immunology|May 9, 2012
Modulation of FcεRI-dependent mast cell response by OX40L via Fyn, PI3K, and RhoARiccardo Sibilano, Barbara Frossi, Ryo Suzuki, et al.Pageof 20